| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |